Similar Search Results

The regulation of prescription drug competition and market responses : patterns in prices and sales following loss of exclusivity

Aitken, Murray L.; Berndt, Ernst R.; Bosworth, Barry; … - 2013

Persistent link: https://www.econbiz.de/10010198694

The regulation of prescription drug competition and market responses : patterns in prices and sales following loss of exclusivity

Aitken, Murray L.; Berndt, Ernst R.; Bosworth, Barry; … - In: Measuring and modeling health care costs, (pp. 243-271). 2018

Persistent link: https://www.econbiz.de/10011812699

Brand loyalty, generic entry and price competition in pharmaceuticals in the quarter century after the 1984 Waxman-Hatch legislation

Berndt, Ernst R.; Aitken, Murray L. - 2010

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. The landmark Waxman-Hatch Act of 1984 represented a "grand compromise" legislation that sought to balance incentives for innovation by...

Persistent link: https://www.econbiz.de/10008688817

Pricing and reimbursement in US pharmaceutical markets

Berndt, Ernst R.; Newhouse, Joseph P. - 2010

Persistent link: https://www.econbiz.de/10008701491

Authorized generic drugs, price competition, and consumers' welfare

Berndt, Ernst R.; Mortimer, Richard; Bhattacharjya, Ashoke - In: Health affairs : at the intersection of health, health … 26 (2007) 3, pp. 790-799

Persistent link: https://www.econbiz.de/10003493146

Pricing and reimbursement in US pharmaceutical markets

Berndt, Ernst R.; Newhouse, Joseph P. - 2010

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important...

Persistent link: https://www.econbiz.de/10008656716